NEW YORK — Predictive Oncology on Wednesday announced that it has priced a public offering of approximately 6.3 million shares of common stock at $.50 per share for gross proceeds of up to roughly $3.2 million.
Dawson James Securities and Paulson Investment Company are acting as exclusive placement agents for the offering.